These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31202990)

  • 1. Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence.
    Zhang Y; Hou Q; Li X; Zhu J; Wang W; Li B; Zhao L; Xia H
    Eur J Med Chem; 2019 Sep; 178():417-432. PubMed ID: 31202990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
    Wang XM; Xin MH; Xu J; Kang BR; Li Y; Lu SM; Zhang SQ
    Eur J Med Chem; 2015; 96():382-95. PubMed ID: 25911625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6,7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells.
    Zhang Y; Chen L; Xu H; Li X; Zhao L; Wang W; Li B; Zhang X
    Eur J Med Chem; 2018 Mar; 147():77-89. PubMed ID: 29421573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
    Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tetrahydroisoquinoline (THIQ) analogue induces mitochondria-dependent apoptosis.
    Sun X; Liu M; Gao L; Mao Y; Zhao D; Zhuang J; Liu L
    Eur J Med Chem; 2018 Apr; 150():719-728. PubMed ID: 29573707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
    Luo H; Yang S; Cai Y; Peng Z; Liu T
    Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.
    OuYang Y; Zou W; Peng L; Yang Z; Tang Q; Chen M; Jia S; Zhang H; Lan Z; Zheng P; Zhu W
    Eur J Med Chem; 2018 Jun; 154():29-43. PubMed ID: 29775935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors.
    Zhang L; Yang Y; Zhou H; Zheng Q; Li Y; Zheng S; Zhao S; Chen D; Fan C
    Eur J Med Chem; 2015 Sep; 102():445-63. PubMed ID: 26310890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives.
    Zhang Y; Huang YJ; Xiang HM; Wang PY; Hu DY; Xue W; Song BA; Yang S
    Eur J Med Chem; 2014 May; 78():23-34. PubMed ID: 24675177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
    Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives Possessing a Trifluoromethyl Moiety as Potential Antitumor Agents.
    Chen M; Cheng S; Dai X; Yu J; Wang H; Xu B; Luo H; Xu G
    Chem Biodivers; 2024 May; 21(5):e202301776. PubMed ID: 38602834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antitumor effects of lupeol quaternary phosphonium salt derivatives.
    Chen Z; Luo R; Xu T; Wang L; Deng S; Wu J; Wang H; Lin Y; Bu M
    Bioorg Med Chem; 2024 Nov; 113():117934. PubMed ID: 39369566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
    Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
    Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
    Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
    Alafeefy AM; Ashour AE
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.